PER 2.47% 7.9¢ percheron therapeutics limited

Ann: Positive Data for ATL1102 in Limb Girdle Muscular Dystrophy, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,036 Posts.
    lightbulb Created with Sketch. 509
    Not totally convincing imo - Looks like more work needs to be done to see if it will be an effective therapy!

    Even though, the possibilities are endless from the inflammation viewpoint!

    "In addition, the researchers examined twitch kinetics, which measures how the muscles ordinarily contract and relax. In the disease model, calf muscle twitch kinetics are increased in comparison to healthy mice. Treatment with the murine version of ATL1102 appeared to partially restore this aspect of muscle behaviour to normal levels in one of the two muscle groups studied. Effects of the murine version of ATL1102 on the levels of fat in the quadriceps muscle (adiposity), and on the biochemical parameters of the muscle tissue, remain under investigation."

    GLTAH's
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.002(2.47%)
Mkt cap ! $81.90M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $230.1K 2.904M

Buyers (Bids)

No. Vol. Price($)
1 51000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 163520 2
View Market Depth
Last trade - 15.57pm 01/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.